Patent · US Active

Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19

US11737999B2 · kind B2 · utility

0Cited by

3References

25Claims

0Family size

Assignee

AXCELLA HEALTH INC. · US

Inventors

Revati Wani · Medford, US
Alison Schecter · Newton, US
Michael Hamill · Wellesley, US
Margaret James Koziel · Needham, US
Matthew Russell · Wellesley, US
Karim Azer · Needham, US
Karen Lavery · Franklin, US
Joel Pradines · Watertown, US

Key dates

Filing date	Jul 25, 2022
Grant date	Aug 29, 2023
Priority date	—
Expiry date	Jul 25, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for treating post-acute sequelae of COVID-19 comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.